2026 CVSL Reimbursement Updates for Boston Scientific Technologies

Fees:

Guests: FREE

Members: FREE

Partners: FREE

Type:

Live Webinar

February 26, 2026 1:00 pm EST

Description

Stay ahead of the 2026 Centers for Medicare & Medicaid Services (CMS) Final Rule changes with a fast, focused update designed for cardiovascular service line (CVSL) clinical, administrative and financial leaders. In this session, you'll get clear guidance on the documentation, coding and reimbursement shifts that matter most for high impact cardiovascular procedures, leveraging Boston Scientific’s key technologies:
• AGENT™ Drug Coated Balloon
• WATCHMAN™ LAAC Device
• FARAPULSE™ Pulsed Field Ablation System

Join us to learn how to:
• Strengthen documentation and coding accuracy
• Reduce denials and low payment risk
• Apply the most important 2026 reimbursement updates with confidence

Prepare your CVSL with the essentials needed to navigate 2026 successfully. Secure your spot today.

Speakers

Gaelle Wine, MBA, Senior Manager, Health Economics and Market Access, Boston Scientific
Lori Wukawitz, MHA, RN, Senior Manager Health Economics and Market Access, Boston Scientific

Moderator

Chris Romeo, Senior Vice President, Ventures, MedAxiom

Ok
This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.